Cross Country Healthcare to Attend the Truist Securities Virtual Human Capital Conference and the Oppenheimer 36th Annual Healthcare Medtech & Services Conference

Cross Country Healthcare, Inc. (Nasdaq: CCRN), a leading healthcare workforce solutions company, has announced its participation in two significant upcoming conferences aimed at enhancing investor relations and showcasing its innovative services. The Truist Securities Virtual Human Capital Conference is scheduled for March 12-13, 2026, where the company will engage in one-on-one investor meetings on March 12. Following this, Cross Country Healthcare will attend the Oppenheimer 36th Annual Healthcare MedTech & Services Conference from March 16-19, 2026, conducting one-on-one meetings on March 17. In attendance will be William J. Burns, Executive Vice President and Chief Financial Officer, and Josh Vogel, Vice President of Investor Relations. It’s important to note that there will be no formal presentations during these conferences.

Cross Country Healthcare has established itself as a key player in the healthcare industry, offering an AI-powered digital platform, Intellify®, and advisory services, bolstered by nearly 40 years of experience in healthcare labor. The Intellify® platform provides health systems with the ability to efficiently manage and optimize their labor ecosystem. By integrating with core hospital systems, Intellify® offers a centralized view that encompasses all service lines—non-clinical, nursing, allied health, and locum tenens. The platform utilizes real-time analytics and AI-driven insights, enabling healthcare leaders to make informed workforce decisions, enhance operational efficiency, reduce labor costs, and ultimately improve patient outcomes.

For more information, stakeholders and potential investors can access Cross Country Healthcare's news releases and SEC filings through their investor relations website. This engagement in investor conferences underscores the company's commitment to transparency and strategic growth within the competitive healthcare landscape.

Cross Country Healthcare, Inc. (Nasdaq: CCRN) is set to engage investors through its participation in two key healthcare conferences—the Truist Securities Virtual Human Capital Conference and the Oppenheimer 36th Annual Healthcare MedTech & Services Conference. As both events occur in March 2026, investors should keep a close eye on the insights and strategic directions discussed.

Cross Country Healthcare focuses on providing workforce solutions powered by its proprietary platform, Intellify®, which integrates workforce management with advanced analytics. This technology enables healthcare systems to optimize their labor resources, lower operational costs, and enhance service delivery—all critical factors as the industry continues to grapple with workforce shortages and rising operational demands.

The absence of formal presentations at the conferences can be viewed as a strategic opportunity for investors. One-on-one meetings led by key executives, including CFO William J. Burns and VP of Investor Relations Josh Vogel, indicate a commitment to fostering intimate investor relationships. These discussions may reveal more nuanced details about recent strategic initiatives, especially pertaining to technology implementation and industry challenges.

Investors should be attentive to topics regarding AI integration and workforce management trends, as these are pivotal in maintaining Cross Country's competitive edge. Additionally, examining how Cross Country plans to leverage these conferences to showcase its innovations could provide insights into future growth trajectories.

Given the negative industry sentiment around staffing shortages and operational efficiencies, analysts might find that Cross Country Healthcare’s proactive investment in technology-driven solutions positions it favorably against market peers. As such, monitoring the company's updates post-conference may yield further clarity on its operational strategy and financial performance, making it a stock worth analyzing for potential long-term investment.